[vc_row][vc_column][grve_title title=”Investing in the future” heading=”h2″][vc_column_text css=””]PhySoft is extending the power of its proven propietary technology—currently improving anemia care in dialysis clinics throughout North America—to support individualized dosing for other tough-to-titrate drugs, including narrow therapeutic index (NTI) drugs.[/vc_column_text][vc_tta_tour active_section=”1″ el_class=”info-card”][vc_tta_section title=”Innovations” tab_id=”1769626945979-4d853972-4976″][vc_single_image image=”5416″ img_size=”650×434″ alignment=”center” css=””][vc_column_text css=””]The underlying architecture of PhySoft’s platform supports adaptation to additional clinical indications where patient-specific responses require more precise dosing for better outcomes.[/vc_column_text][/vc_tta_section][vc_tta_section title=”Collaborations” tab_id=”1769626865386-bb11c38f-0460″][vc_single_image image=”5415″ img_size=”650×434″ alignment=”center” css=””][vc_column_text css=””]PhySoft’s pipeline represents a growing set of opportunities to apply the company’s proven proprietary technology to additional therapies and patient populations. PhySoft’s strategic collaborations align clinical need, scientific rigor, improved outcomes, and positive impacts on patient care.[/vc_column_text][/vc_tta_section][vc_tta_section title=”Therapeutics” tab_id=”1769708881850-29ac0286-8cf1″][vc_single_image image=”5420″ img_size=”650×434″ css=””][vc_column_text css=””]

Difficult-to-dose and NTI drugs require precise dosing to achieve the intended therapeutic effect, ensure patient stability, and support long-term treatment success.

These are exactly the kinds of therapies where precision dosing can make the greatest impact, improving patient safety, minimizing variability, and reducing unnecessary drug spend.

[/vc_column_text][/vc_tta_section][vc_tta_section title=”Product roadmap” tab_id=”1769626379933-f3504df0-cabc”][vc_single_image image=”5417″ img_size=”650×434″ alignment=”center” style=”vc_box_shadow” css=””][vc_column_text css=””]Pipeline activities reflect a disciplined, evidence-driven approach to ongoing scientific and clinical assessment, feasibility analyses, and prioritization based on clinical complexity and potential benefit.[/vc_column_text][/vc_tta_section][/vc_tta_tour][/vc_column][/vc_row][vc_row section_type=”fullwidth-element” footer_feature=”yes” font_color=”#333333″ row_title=”cta” margin_bottom=”0″ padding_top=”15″ padding_bottom=”75″ section_id=”cta” el_class=”no-print”][vc_column width=”1/2″ tablet_width=”1″ tablet_sm_width=”1″ css=”.vc_custom_1755101996482{margin-top: 45px !important;margin-bottom: 50px !important;padding-right: 3% !important;padding-left: 5% !important;}”][grve_title title=”Get in touch” heading=”h2″][vc_column_text css=””]PhySoft is actively expanding its innovative healthcare solutions to better serve patients and improve outcomes across a broadening range of disease states and indications. As we scale our impact, researchers, clinicians, and healthcare organizations are invited to join us in these efforts.[/vc_column_text][vc_column_text css=””]Contact us today to explore ways in which we can work together.[/vc_column_text][/vc_column][vc_column width=”1/2″ tablet_width=”1″ tablet_sm_width=”1″ css=”.vc_custom_1755102184289{padding-right: 5% !important;padding-left: 3% !important;}”][vc_row_inner][vc_column_inner el_class=”bg-blue white” css=”.vc_custom_1755102155867{padding-right: 5% !important;padding-left: 5% !important;}”]